Maria Alejandra Castilla Bolanos1,2, Rajshree Ghosh Biswas1, Matthias Niemtiz3, Andre simpson1, Carol Schuurmans1,2, and Jamie Near1,2
1University of Toronto, Toronto, ON, Canada, 2Sunnybrook Research Institute, Toronto, ON, Canada, 3NMR Solutions, Helsinki, Finland
Synopsis
Keywords: Data Processing, Spectroscopy, Organoids
Motivation: 12
Goal(s): 2
Approach: 2
Results: 2
Impact: 2
Introduction
Cerebral organoids (COs), derived from pluripotent stem cells,
are three-dimensional self-organising clusters of cultured brain tissue resembling
the human brain’s genetics and phenotype1–4. Establishing
an in vitro neurophysiology model requires novel methodologies to assess
their similarity to the brain and translate therapeutics from COs to the
clinic.
NMR Spectroscopy (NMRS) offers non-invasive,
high-reproducibility, non-destructive analysis, providing quantification of
metabolites involved in different cellular and metabolic pathways5–8. However,
NMRS faces challenges in obtaining high-quality data from COs, including magnetic
field homogeneity and dipolar coupling effects, acquisition times, sample
concentration, and biomolecular weight6,7,9,10. These
limitations result in broad linewidths, non-flat baselines, overlapping peaks, and
a low signal-to-noise ratio, complicating further analysis of COs neurochemical
profile. While pre-processing is essential for noise reduction and spectrum
correction7,9, using approaches
such as high-resolution magic-angle spinning (HR-MAS) NMR can improve the
signal quality from small-volume, low-concentration samples11,12.
HR-MAS NMR is a powerful tool to study COs as fast spinning reduces
linewidth, facilitating metabolite identification. However, the quantification of HR-MAS NMR
spectra from complex metabolite mixtures such as brain tissue remains
complicated11,12. Analysis of in vivo brain MR spectra is
routinely performed using linear combination modelling software such as LCModel,
ABfit, FSL-MRS and OSPREY. These tools perform well even in the presence of minor
basis set imperfections, due to the relatively high degree of line-broadening
observed in vivo. In contrast, the very narrow linewidths observed In
HR-MAS spectra result in poor performance of standard linear combination
modelling tools if there are relatively minor errors in the basis set parameters,
such as the chemical shifts and J-coupling constants. Therefore, a methodology with
flexibility to adjust the coupling and chemical shifts of basis spectra is
needed for accurate linear combination modelling of HR-MAS spectra of complex
mixtures6,10,15.
In this work, we explore the use of a new software tool for
analysis of HR-MAS NMR spectra for improved metabolite identification and
quantification in COs.Methods
Here, we propose metabolite identification and quantification
in 500 MHz HR-MAS NMR spectra from ~100-day-old COs derived from Pluripotent
Stem Cells, adjusting chemical shifts and J-coupling constants for a consistent
fitting model. After pre-processing data in FIDA (Matlab v.R2023b)16 and Topspin
v.4.3.0 (Bruker) to visualize and correct phase and baseline, we employed Cosmic
Truth (CT; ct.nmrsolutions.io) from NMR solutions, a quantum
mechanical spectral analysis tool for 1D-1H NMR spectroscopy, to extract NMR
parameters, including chemical shifts and coupling constants from COs NMR
spectra with high order effects and overlapping signals. Acquired HR-MAS spectra
were loaded into CT, and initial basis functions were loaded using the
simplified molecular input line entries (SMILEs) of metabolites of interest,
followed by semi-automatic adjustment of coupling and chemical shifts to
achieve spectral similarity with the spin system entries. For metabolite quantification, a reference
scan was performed in a phantom containing a 20mM solution of alanine.
Metabolite concentrations were then estimated by measuring their signal
intensity relative to the alanine reference signal. Results
We identified and quantified 17 metabolites in HR-MAS NMR spectra
of ~100 day-old COs, revealing important distinctions from the human
brain. NAA is notably absent in COs, which may be due to early maturation stages
or the absence of crucial neuronal support cell interactions, like microglia
and oligodendrocytes. In contrast, COs exhibit elevated levels of lactate, ethanol,
choline, phosphocreatine, glycine, and glucose. The high concentration of
lactate may stem from inner-core hypoxia within COs, suggesting potential
anaerobic glycolysis in this cerebral platform.
Future research will focus on metabolic pathways activated in
later COs maturation stages and compare genetic expression with HR-MAS NMR quantification.Conclusions
This study proposes an analysis method for the identification
and quantification of metabolites in cerebral organoids, which account for flexible
parameters, such as chemical shifts, and coupling constants. It addresses many
of the shortcomings of conventional linear combination modelling approaches for
the analysis of high-resolution NMR data. In addition, this method may extend its
application to quantify metabolites and small molecules in different human
brain platforms, going beyond cerebral organoids. Acknowledgements
This work is supported by the Canadian Institutes for Health
Research (JN, AS and CS, Grant #: PJT-183715).References
1. Chiaradia, I., and Lancaster, M.A.
(2020). Brain organoids for the study of human neurobiology at the interface of
in vitro and in vivo. Nat Neurosci 23, 1496–1508.
10.1038/s41593-020-00730-3.
2. Di Lullo, E., and
Kriegstein, A.R. (2017). The use of brain organoids to investigate neural
development and disease. Nat Rev Neurosci 18, 573–584.
10.1038/nrn.2017.107.
3. Eichmüller, O.L., and
Knoblich, J.A. (2022). Human cerebral organoids — a new tool for clinical
neurology research. Nat Rev Neurol 18, 661–680.
10.1038/s41582-022-00723-9.
4. Frontiers | In vitro
Models of Neurodegenerative Diseases
https://www.frontiersin.org/articles/10.3389/fcell.2020.00328/full.
5. Alderson, T.R., and
Kay, L.E. (2021). NMR spectroscopy captures the essential role of dynamics in
regulating biomolecular function. Cell 184, 577–595.
10.1016/j.cell.2020.12.034.
6. Emwas, A.-H., Roy, R.,
McKay, R.T., Tenori, L., Saccenti, E., Gowda, G.A.N., Raftery, D., Alahmari,
F., Jaremko, L., Jaremko, M., et al. (2019). NMR Spectroscopy for Metabolomics
Research. Metabolites 9, 123. 10.3390/metabo9070123.
7. Emwas, A.-H., Saccenti,
E., Gao, X., McKay, R.T., dos Santos, V.A.P.M., Roy, R., and Wishart, D.S.
(2018). Recommended strategies for spectral processing and post-processing of
1D 1H-NMR data of biofluids with a particular focus on urine. Metabolomics 14,
31. 10.1007/s11306-018-1321-4.
8. Kumar, S., Villanueva,
M., and Zuklic, J. (2016). Quantitative Determination of Acetaminophen by
q-NMR. Comparison of Analysis with TopSpin software. MestReNova software, and
ERETIC Method. GSU Research Day.
9. Wishart, D.S. (2019).
NMR metabolomics: A look ahead. Journal of Magnetic Resonance 306,
155–161. 10.1016/j.jmr.2019.07.013.
10. Lin, A., Andronesi, O.,
Bogner, W., Choi, I.-Y., Coello, E., Cudalbu, C., Juchem, C., Kemp, G.J.,
Kreis, R., Krššák, M., et al. (2021). Minimum Reporting Standards for in vivo
Magnetic Resonance Spectroscopy (MRSinMRS): Experts’ consensus recommendations.
NMR in Biomedicine 34, e4484. 10.1002/nbm.4484.
11. Vonhof, E.V., Piotto,
M., Holmes, E., Lindon, J.C., Nicholson, J.K., and Li, J.V. (2020). Improved
Spatial Resolution of Metabolites in Tissue Biopsies Using High-Resolution
Magic-Angle-Spinning Slice Localization NMR Spectroscopy. Anal. Chem. 92,
11516–11519. 10.1021/acs.analchem.0c02377.
12. Hassan, Q., Dutta
Majumdar, R., Wu, B., Lane, D., Tabatabaei-Anraki, M., Soong, R., Simpson,
M.J., and Simpson, A.J. (2019). Improvements in lipid suppression for 1H
NMR-based metabolomics: Applications to solution-state and HR-MAS NMR in
natural and in vivo samples. Magnetic Resonance in Chemistry 57,
69–81. 10.1002/mrc.4814.
13. Oeltzschner, G. Osprey
Documentation. (2018) RainCloudPlots
tutorials and codebase (Version v1.1). Zenodo.
http://doi.org/10.5281/zenodo.3368186
14. Izquierdo-Garcia,
J., Villa Valverde, P., Kyriazis, A., Puerto-Nevado, L., Pérez-Rial, S.,
Rodriguez, I., Hernandez, N., and Ruiz-Cabello, J. (2011). Descriptive
Review of Current NMR-Based Metabolomic Data Analysis Packages. Progress in
nuclear magnetic resonance spectroscopy 59, 263–270.
10.1016/j.pnmrs.2011.02.001.
15. Liu, Y.,
Navarro-Vázquez, A., Gil, R.R., Griesinger, C., Martin, G.E., and Williamson,
R.T. (2019). Application of anisotropic NMR parameters to the confirmation of
molecular structure. Nat Protoc 14, 217–247. 10.1038/s41596-018-0091-9.
16. FID-A – Advanced MR
spectroscopy processing and simulation – Open Source Imaging
https://www.opensourceimaging.org/project/fid-a-advanced-processing-and-simulation-of-mr-spectroscopy/.